iShares MSCI Indonesia ETF vs Liquidia Corporation Common Stock — how do they compare? iShares MSCI Indonesia ETF trades at $11.83 (market cap $398.15M), while Liquidia Corporation Common Stock trades at $34.2 (market cap $3.04B). The key difference: Liquidia Corporation Common Stock is far larger — about 7.6× iShares MSCI Indonesia ETF's market cap, and Liquidia Corporation Common Stock is more actively traded (21,111,778 versus 3,087,911). Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Indonesia ETF for 76 Days and Liquidia Corporation Common Stock for 0 Days on average.
| EIDO | LQDA | |
|---|---|---|
Market Cap | $398.15M | $3.04B |
Volume | 3,087,911 | 21,111,778 |
52-Week High | $19.22 | $91.03 |
52-Week Low | $10.80 | $22.02 |
Typical Hold Time | 76 Days | 0 Days |
Sector | — | Health |
Enterprise Value | — | $2.94B |
Signals from Pluang's Aura AI — not financial advice
EIDO (iShares MSCI Indonesia ETF) trades at $11.71, up 0.34% with bearish technical signals from moving averages and neutral oscillators. The ETF faces weak price action despite trading at a bargain valuation of 8.7x P/E. Recent news highlights foreign capital rotation away from Asian equities and Indonesia's limited benefit from commodity gains, with 44% financials weighting constraining growth potential.
Outlook remains cautious due to technical downtrend and sector concentration risks. The low valuation offers potential value, but persistent weak momentum and limited EPS growth of 5.9% temper upside. Key risks include dependence on financial sector performance and broader Asian market sentiment shifts.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Indonesia. The fund is non-diversified.
Read more on EIDO →Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →